Skip to main content

CARY STREET PARTNERS INVESTMENT ADVISORY LLC

Position in HALO — Halozyme Therapeutics, Inc.

CIK 1766904 RICHMOND, VA

Position in HALO

as of Jun 30, 2026 · filed Jul 17, 2026
Position Value
$13,539
+$5,720 QoQ
Shares Held
173
+43.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#565
of 664 holders
Holding Since
Jun 2022
17 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in HALO Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

CARY STREET PARTNERS INVESTMENT ADVISORY LLC holds $764,016 across 7 Biotechnology names. HALO ranks #4 (1.8% of the industry book) .

# Ticker Company Shares Value (USD) Open
4 HALO
Halozyme Therapeutics, Inc.
This page
173 $13,539

All Filings in HALO

Export CSV
17 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $13,539 173
2026-03-31 $7,819 121
2025-12-31 $2,017 30
2025-09-30 $2,933 40
2025-06-30 $520 10
2025-03-31 $7,273 114
2024-12-31 $4,781 100
2024-09-30 $6,876,470 120,134
2024-06-30 $1,060,185 20,248
2024-03-31 $827,349 20,338
2023-12-31 $751,692 20,338
2023-09-30 $776,911 20,338
2023-06-30 $733,591 20,338
2023-03-31 $776,708 20,338
2022-12-31 $1,155,809 20,313
2022-09-30 $802,187 20,288
2022-06-30 $889,592 20,218